| scholarly article | Q13442814 |
| P2093 | author name string | Weintraub WS | |
| King SB 3rd | |||
| Kosinski AS | |||
| Brown CL 3rd | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angioplasty | Q539795 |
| P304 | page(s) | 6-14 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Can restenosis after coronary angioplasty be predicted from clinical variables? | |
| P478 | volume | 21 |
| Q74006780 | Achieving optimal results with standard balloon angioplasty: can baseline and angiographic variables predict stent-like outcomes? |
| Q73782302 | Acute myocardial infarction: are diabetics different? |
| Q36603724 | Association between C1019T polymorphism of the connexin37 gene and coronary heart disease in patients with in-stent restenosis |
| Q71774924 | Atherosclerosis and restenosis: reflections on the Lovastatin Restenosis Trial and Scandinavian Simvastatin Survival Study |
| Q37873867 | Chlamydia pneumoniae and luminal narrowing after coronary angioplasty |
| Q34876677 | Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision |
| Q44003340 | Clinical and angiographic outcomes of diabetic patients after coronary stenting: a comparison of native vessel stent restenosis rates in different diabetic subgroups |
| Q52056140 | Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. |
| Q36833064 | Comparative study of Nd:YAG laser angioplasty at 1.06 microns, 1.32 microns, and 1.44 microns wavelengths: decreased vascular spasm and early mortality with 1.44 microns laser ablation |
| Q44065287 | Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries |
| Q45938400 | Comparison of coronary stent expansion by intravascular ultrasonic imaging in younger versus older patients with diabetes mellitus. |
| Q28219874 | Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study |
| Q78016623 | Coronary artery stenting |
| Q36576204 | Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients |
| Q36333923 | Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome |
| Q74434332 | Differential restenosis rate of individual coronary artery sites after multivessel angioplasty: implications for revascularization strategy. CABRI Investigators. Coronary Angioplasty versus Bypass Revascularisation Investigation |
| Q74523215 | Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients |
| Q35009992 | Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies |
| Q73453210 | Greater late lumen loss after successful coronary balloon angioplasty in the proximal left anterior descending coronary artery is not explained by extent of vessel wall damage or plaque burden |
| Q77538428 | Hybrid revascularization feasibility in minimally invasive direct coronary artery bypass grafting combined with percutaneous transluminal coronary angioplasty in patients with acute coronary syndrome and multivessel disease |
| Q56945296 | Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I) |
| Q44835578 | Importance of lesion length on new device angioplasty of native coronary arteries. NACI Investigators. New Approaches to Coronary Interventions |
| Q77295625 | Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result |
| Q73017304 | Influence of age on outcome after percutaneous transluminal coronary angioplasty |
| Q73069700 | Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting |
| Q43909911 | Influence of diabetes on >10-year outcomes after percutaneous coronary intervention |
| Q35070955 | Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects |
| Q58145267 | Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus |
| Q73857137 | Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation |
| Q36812937 | Long-term follow-up of coronary angioplasty in patients with diabetes compared with nondiabetics |
| Q73378644 | Long-term outcome in patients with unstable angina treated by coronary balloon angioplasty |
| Q73308440 | Long-term outcome of coronary balloon angioplasty in diabetic patients |
| Q77522059 | Medical therapies for the prevention of restenosis after percutaneous coronary interventions |
| Q74780017 | Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study |
| Q35374333 | Myocardial "hybrid" revascularisation with minimally invasive direct coronary artery bypass grafting combined with coronary angioplasty: preliminary results of a multicentre study |
| Q37845260 | Novel QCA methodologies and angiographic scores |
| Q71877956 | Obstacles to outcomes analysis in percutaneous transluminal coronary revascularization |
| Q74027445 | Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease |
| Q35813673 | Percutaneous coronary intervention in diabetics |
| Q73597752 | Platelet aggregability and occurrence of restenosis following coronary angioplasty |
| Q73857145 | Predictive factors of restenosis after coronary stent placement |
| Q53939013 | Predictors for restenosis after angioplasty of chronic coronary occlusions. |
| Q57606058 | Predictors of Restenosis After Coronary Stent Implantation |
| Q35149725 | Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus |
| Q73901503 | Predictors of clinical outcome following percutaneous intervention for in-stent restenosis |
| Q36411220 | Present status of outcome prediction of invasive coronary treatment by using genetic markers |
| Q43833274 | Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells |
| Q44454489 | Prospective evaluation of hydroperoxide plasma levels and stable nitric oxide end products in patients subjected to angioplasty for coronary artery disease |
| Q34058201 | Provisional stenting strategies: systematic overview and implications for clinical decision-making |
| Q28165832 | Rationale and design of the randomized, multicenter, Cilostazol for restenosis (CREST) trial |
| Q73128785 | Relation between coronary artery disease, baseline clinical variables, revascularization mode, and mortality. CABRI Participants. Coronary Angioplasty vs. Bypass Revascularisation Investigation |
| Q56945461 | Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions |
| Q47231156 | Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry Report). |
| Q37930965 | Restenosis after PCI. Part 1: pathophysiology and risk factors |
| Q73344123 | Restenosis after coronary placement of various stent types |
| Q50902081 | Restenosis after coronary stenting in current clinical practice. |
| Q40975043 | Restenosis following coronary angioplasty: clinical presentations and therapeutic options |
| Q78106212 | Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients |
| Q34793647 | Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting |
| Q33906474 | Revascularization strategies in patients with diabetes: evolving concepts |
| Q47734969 | Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients |
| Q53660151 | The Spanish trial: are national randomized trials a necessary evil? |
| Q77313110 | The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation |
| Q74425598 | The influence of diabetes mellitus on late clinical outcomes following coronary stent implantation |
| Q36748161 | Therapy insight: diabetes and drug-eluting stents |
| Q43185883 | Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention |
| Q73587523 | [A comparison of the clinical and angiographic evolution of diabetic and nondiabetic patients treated by conventional angioplasty versus stent implantation in native coronary arteries] |
| Q73118426 | [Blood coagulation, genetics and post-angioplasty restenosis] |
Search more.